Composition for preventing, alleviating or treating metabolic diseases, containing amodiaquine as active ingredient
US10004727B2 · kind B2 · utility
0Cited by
1References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 16, 2016 |
| Grant date | Jun 26, 2018 |
| Priority date | — |
| Expiry date | Feb 16, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel use of a composition containing, as an active ingredient, an amodiaquine compound or a pharmaceutically acceptable salt thereof and specifically, to a metabolic disease prevention, alleviation or treatment use of a composition containing, as an active ingredient, an amodiaquine compound or a pharmaceutically acceptable salt thereof, the composition activating both peroxisome proliferator-activated receptor-gamma (PPAR-γ) and peroxisome proliferator-activated receptor-alpha (PPAR-α).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.